Related Experiment Video
Updated: Apr 23, 2026

09:16
Use of a Video Scoring Anchor for Rapid Serial Assessment of Social Communication in Toddlers
Published on: March 14, 2018
13.0K
Screening for ASD with the Korean CBCL/1½-5
Leslie Rescorla1, Young Ah Kim2, Kyung Ja Oh3
1Bryn Mawr College, 101N. Merion Avenue, Bryn Mawr, PA, 19010, USA. lrescorl@brynmawr.edu.
Journal of Autism and Developmental Disorders
|September 21, 2014
Summary
The Child Behavior Checklist (CBCL/1½-5) effectively screens for autism spectrum disorder (ASD) in preschoolers. It showed high sensitivity in identifying ASD compared to other developmental and psychiatric conditions.
Area of Science:
- Child Psychology
- Developmental Pediatrics
- Psychometric Evaluation
Background:
- The Child Behavior Checklist for ages 1½–5 (CBCL/1½-5) is a widely used behavioral screening tool.
- Its utility in screening for autism spectrum disorders (ASD) requires validation in diverse populations.
Purpose of the Study:
- To evaluate the effectiveness of the CBCL/1½-5 as a screening tool for autism spectrum disorders (ASD) in Korean preschoolers.
- To assess the performance of specific CBCL/1½-5 scales and items in differentiating ASD from other developmental and psychiatric conditions.
Main Methods:
- A cross-sectional study involving 456 Korean preschoolers, including groups with ASD, developmental delay (DD), other psychiatric disorders (OPD), and non-referred (NR) children.
- Analysis of CBCL/1½-5 scores, focusing on the Withdrawn and DSM-Pervasive Developmental Problems (DSM-PDP) scales and specific ASD-related items.
Main Results:
- Children with ASD exhibited significantly higher scores on the Withdrawn and DSM-PDP scales compared to other groups.
- A T ≥ 65 cutpoint on the DSM-PDP scale achieved 80% sensitivity for identifying ASD.
- Specificity varied across comparison groups: 87% for NR, 55% for OPD, and 60% for DD.
Conclusions:
- The CBCL/1½-5 demonstrates good performance in Level 1 screening for ASD, particularly in differentiating ASD from the general population.
- Findings support the CBCL/1½-5's utility as an initial screening instrument for ASD in non-Western populations.
- Further research may refine cutpoints to improve specificity in clinical populations.

